Another Potential Blockbuster Drug namely Bardoxolone ( refer this article published earlier: http://www.pharmablockbusters.info/2011/12/bardoxolone-potential-mega-blockbuster.html ) felt the axe as it failed to clear the Ph III Clinical trials due to concerns about death and "excess serious adverse events" in patients taking the first-in-class antioxidant...
Posts
